Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
about
Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug deliveryProtective effects of bestatin in the retina of streptozotocin-induced diabetic mice.Reduced retinal microvascular density, improved forepaw reach, comparative microarray and gene set enrichment analysis with c-jun targeting DNA enzymeExploring leptin antagonism in ophthalmic cell modelsPEDF improves cardiac function in rats with acute myocardial infarction via inhibiting vascular permeability and cardiomyocyte apoptosis.Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammalsDesigner Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity.Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeabilityPigment Epithelium-Derived Factor (PEDF) Improves Ischemic Cardiac Functional Reserve Through Decreasing Hypoxic Cardiomyocyte Contractility Through PEDF Receptor (PEDF-R).Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Vascular complications and diabetes: current therapies and future challenges.Next-generation therapeutic solutions for age-related macular degeneration.Role of receptor-mediated endocytosis in the antiangiogenic effects of human T lymphoblastic cell-derived microparticles.Neural Stem Cell-based Intraocular Administration of Pigment Epithelium-derived Factor Promotes Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Crush Injury in Rat: An Experimental Study.
P2860
Q27007119-FEFCC611-2011-45ED-9888-667290922561Q33878491-56E53C5F-9C8C-4315-8D0A-79A4F3A7F90DQ34344676-B87900F6-793C-4898-AB32-7CC3170B1DCCQ35009436-019FAB7E-7AAA-44A5-BECA-92B4B0F9F1DFQ35381258-CE4B88E2-34F3-4378-9374-CD0BEE57006EQ36051041-AD50B744-BF0D-47E4-8C10-4295E4A9945DQ36176814-9F867DA6-FFC6-45DB-BAA4-5592FD358A15Q36502977-D7163D9E-2FC4-489E-84E6-BCBCCEE5A4F5Q37148310-69CF3C8A-DA39-4483-A86B-56A7AD331D9BQ37240624-5E646D73-96DD-4E89-B3E1-5FA0FC18E7F4Q37627442-5C8FBD96-FB04-4CB5-9F73-8163C9198333Q37978317-4AF11982-D61E-461E-86BA-2FF2EC94FEE7Q38138089-75BA6EDF-F9D5-4C61-BB5A-764E88FF6442Q39396080-222443EA-3F06-498E-97F4-35FF22052353Q39433723-947AA259-A7B2-4FAB-BFD8-642ED571AA82
P2860
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
@en
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
@nl
type
label
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
@en
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
@nl
prefLabel
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
@en
Emerging therapeutic approaches in the management of retinal angiogenesis and edema.
@nl
P2860
P1476
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
@en
P2093
Tien Y Wong
P2860
P2888
P304
P356
10.1007/S00109-010-0709-Z
P577
2010-12-18T00:00:00Z